Home » Topics » Regulatory » Patents

Patents
RSS

Novel tyrosinase inhibitors for skin hyperpigmentation claimed by Galderma

Oct. 30, 2006

New agents for obesity and other metabolic disorders imparted in recent patents

Oct. 30, 2006

Recent patents disclose novel diagnostic agents

Oct. 27, 2006

Novel P2Y12 receptor antagonists emerge from Pfizer R&D

Oct. 27, 2006

Novel antiarthritic agents recently patented

Oct. 27, 2006

Recent patent literature discloses novel analgesic agents

Oct. 26, 2006

Therapeutic agents for arteriosclerosis, hypertension, etc. disclosed in recent patents

Oct. 26, 2006

Recent patents report new treatment strategies for respiratory disorders

Oct. 26, 2006

Recent patents cover possible novel treatment options for diabetes and associated disorders

Oct. 25, 2006

Novel agents for HIV infection patented

Oct. 25, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...